Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.
By I. Vergote, J. De Brabanter, A. Fyles, K. Bertelsen, N. Einhorn†, P. Sevelda, M. Gore, J. Kærn, Herman Verrelst, Kjerstin Sjövall and 4 more. The Lancet, 2001
614 citations recorded by the source corpus.
Subfields: Oncology, Public Health, Environmental and Occupational Health, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/5c2a12e8146e38950c625298992accd29901cd96
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Public Health, Environmental and Occupational Health
In Reproductive Medicine
Citations in the corpus
- ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. (2019, background): “affect prognosis, and must be avoided.(87) Nevertheless, the mini-”
- Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. (2003, background): “[16] found that stage Ic disease had a prognosis similar to that of stage Ib disease.”
- Preoperative prediction of malignancy of ovarian tumors using least squares support vector machines (2003, neutral): “In contrast, the 5-year survival for patients with stage I ovarian cancer is about 80% [29].”
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum (2014, background): “Whereas some studies found that intraoperative capsule rupture portends a higher risk of disease recurrence [19,20], others did not [14,15,18,21,22].”
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease (2019, methodology): “Regardless of the approach used, rupture of an intact tumour could alter the FIGO staging and affect prognosis, and must be avoided [87].”